![Keynote Lecture with Professor Sarah Tabrizi - Gene targeting therapies for Huntington’s disease: What does the future hold for neurodegenerative disorders? 7 Sarah Tabrizi](https://wcp2023.org/wp-content/uploads/2020/09/Sarah-Tabrizi-300.jpg)
Keynote Lecture with Professor Sarah Tabrizi – Gene targeting therapies for Huntington’s disease: What does the future hold for neurodegenerative disorders?
Speaker
-
Professor Sarah TabriziDirector of the UCL Huntington’s Disease (HD) Centre, Joint Head of Department Neurodegenerative Disease at the UCL Queen Square Institute of Neurology
Country: UK
Professor Sarah Tabrizi is Director of the UCL Huntington’s Disease (HD) Centre, Joint Head of Department Neurodegenerative Disease at the UCL Queen Square Institute of Neurology, a Principal Investigator at the UK Dementia Research Institute, and Consultant Neurologist at the National Hospital for Neurology and Neurosurgery.
In addition to a basic bench science programme focussing on basic cellular mechanisms of neurodegeneration in HD that can be harnessed for therapeutics, she also leads a large translational research programme that is working towards finding effective disease-modifying treatments for HD. She was global clinical PI on the world’s first gene targeting study for HD using anti-sense oligonucleotide therapy.
Leave A Comment